Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare's Q2 Revenues Grow 10 Percent as Profit Jumps 18 Percent

NEW YORK (GenomeWeb News) - GE Healthcare today said that second-quarter revenues climbed 10 percent as earnings increased 18 percent.
 
For the quarter ended June 30, GE Healthcare had $4.1 billion in revenues, up from $3.8 billion during the same quarter in 2005.
 
GE Healthcare's earnings for the quarter increased to $795 million from $672 million in the second quarter of 2005.
 
GE's total revenues for the quarter were $39.9 billion, up from $36.5 billion during the same period last year.
 
GE did not break out its research and development expenses for the Healthcare segment.
 
As of June 30, GE reported $56.1 billion in cash and marketable securities.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.